Loading......

IMFINZI DOSING

Dosing and method of administration

INDIVIDUAL WEIGHT-BASED DOSING1

IMFINZI individual weight-based posology: 10 mg/kg of IMFINZI infused via IV for 1 hour once every 2 weeks.
IMFINZI individual weight-based posology: 10 mg/kg of IMFINZI infused via IV for 1 hour once every 2 weeks.
  • IMFINZI is supplied as single-use vials that contain either 500 mg/10 mL or 120 mg/2.4 mL.Refer to the IMFINZI SmPC for further information on storage, dilution, and administration instructions
  • Treatment must be initiated and supervised by a physician experienced in the treatment of cancer1
  • Infusion-related reactions with IMFINZI were observed in 1.9% of patients in the PACIFIC study1

It is recommended to continue treatment for clinically stable patients with initial evidence of disease progression until disease progression is confirmed.1

Continue treatment with IMFINZI for 12 months in the absence of disease progression or unacceptable toxicity1

PREVIOUS
View the safety and tolerability
profile for IMFINZI

VIEW SAFETY DATA

patients_profile
patients_profile
posology
posology

NEXT
Which of your patients could
benefit from IMFINZI?

INTERACTIVE CASE STUDIES

Reference: 1. IMFINZI - UK Summary of Product Characteristics. Date: September 2020.